Sea of people tactics! India develops app to report drug black market and fake drugs

Source: Biovalley 2015-03-30 India has always been known as the "world pharmacy" The generic pharmaceutical industry is very developed Generally speaking, once expensive drugs in western countries are listed, Indian pharmaceutical enterprises can copy similar products under the protection of their own patent law " Authentic "Indian generic drugs, which are almost the same as patent drugs in terms of dosage, safety, efficacy, quality, effect and indications, but are not bound by patent Because there is no need to pay patent fee, the average price of generic drugs is only 20% - 40% of patent drugs, and the difference of individual varieties is even more than 10 times Due to India's special patent law system, the drug sales and production in India are different from those in other countries This has also resulted in illegal phenomena such as drug black market in India, while the prices of some popular drugs have also been inflated This also brings great pressure to the national Pharma pricing authority (NPPA), the drug management department of India On the other hand, due to India's large population and unbalanced development in different regions, there are many vacuum areas in NPPA management In order to effectively deal with this problem, NPPA plans to open a special portal and mobile app, which are specially used for citizens to report the problem of fake drugs and the phenomenon of high drug prices Government officials said the government hopes to effectively combat the widespread drug black market in India through this way This is only the first step of the Indian government's attack After that, NPPA will collect the price data of domestic medicine based on these drug information systems and monitor the information of domestic medicine industry in real time In recent years, with the special patent law in India, many pharmaceutical companies in India can quickly track the latest international generic drugs and export them at a very low price With this advantage, India's exports of generic drugs have been on the rise in recent years Last year, the rapid "copycat" of India's anti hepatitis C drug sovaldi, which Gilead company swept the world, caused a great stir